Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-17-022854
Filing Date
2017-04-28
Accepted
2017-04-28 08:02:05
Documents
5
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A v464711_defa14a.htm DEFA14A 10525
2 GRAPHIC image_001.jpg GRAPHIC 68593
3 GRAPHIC image_002.jpg GRAPHIC 116136
4 GRAPHIC image_003.jpg GRAPHIC 36709
5 GRAPHIC image_004.jpg GRAPHIC 13357
  Complete submission text file 0001144204-17-022854.txt   335413
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36357 | Film No.: 17791720
SIC: 2834 Pharmaceutical Preparations